References
- Cai W, Chen K, Mohamedali KA. PET of vascular endothelial growth factor receptor expression. J Nucl Med 2006;47:2048–56
- Pandey SK, Gryshuk AL, Sajjad M, et al. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible “see and treat” approach. J Med Chem 2005;48:6286–95
- Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004;47:3897–915
- Wilson BC. Light sources for photodynamic therapy. Photodyn Ther News 1998;4:6–8
- Shriver DF, Atkins PW. Inorganic chemistry. 3rd ed. Oxford, UK: Oxford University Press; 1999
- Abrams MJ, Murrer BA. Metal compounds in pheraopy and diagnosis. Science 1993;261:725–730
- Calin MA, Parascaa SV. Photodynamic therapy in oncology. J Optoelect Adv Mater 2006;8:1173–9
- Ali H, van Lier JE. Metal complexes as photo- and radio-sensitizers. Chem Rev 1999;99:2379–450
- Selman H, Hampton JA, Morgan AR, et al. Copper benzochlorin, a novel photosensitizer for photodynamic therapy: effects on a transplantable urothelial tumor. Photochem Photobiol 1993;57:681–5
- Smith KM, Goff DA, Simpson DJ. Meso substitution of chlorophyll derivatives: direct route for transformation of bacterio pheophorbides into bacteriopheophorbides. J Am Chem Soc 1985;107:4946–54
- Huber V, Sengupta S, Würhtner F. Structure–property relationships for self-assembled zinc chlorine light-harvesting dye aggregates. J Eur Chem 2008;14:7791–807
- Ocakoglu K, Bayrak E, Onursal M, et al. Evaluation of 99mTc-pheophorbide-a use in infection imaging: a rat model. Appl Radiat Isot 2011;69:165–8
- Ozgur A, Lambrecht FY, Ocakoglu K, et al. Synthesis and biological evaluation of radiolabeled photosensitizer linked bovine serum albumin nanoparticles as a tumor imaging agent. Inter J Pharm 2012;422:472–8
- Ashrafi SA, Hosseinimehr SJ, Varmira K, Abedi SM. Radioimmunotherapy with 131I-bevacizumab as a specific molecule for cells with overexpression of the vascular endothelial growth factor. Can Bioth Radiopharm 2012;27:420–5
- Chen K, Preub A, Hackbarth S, et al. Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. Photochem Photobiol B 2009;96:66–74
- Babar AK, Singh AK, Goel HC, et al. Evaluation of 99mTc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy. Nucl Med Biol 2000;27:419–26
- Yang SG, Chang JE, Shin B, et al. 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging. J Mater Chem 2010;20:9042–6
- Yurt Lambrecht F, Durkan K, Yıldırım Y, Acar Ç. Labeling of acetaminophen with I-131 and biodistribution in rats. Chem Pharm Bull 2006;54:245–7
- Enginar H, Ünak P, Lambrecht FY, et al. Radiolabeling of codeine with 131I and biodistribution in rats. J Radioanal Nucl Chem 2009;280:367–74
- Kowalsky RC, Perry JR. Radiopharmaceuticals in nuclear medicine practice. New Jersey: Appleton & Lange, a publishing division of Prentice-Hall; 1987
- Seyitoglu B, Yurt Lambrecht F, Durkan K. Labeling of apigenin with 131I and bioactivity of 131I-apigenin in male and female rats. J Radioanal Nucl Chem 2009;279:867–73
- Bayrak E, Yurt Lambrecht F, Durkan K, Yilmaz O. In vitro evaluation, biodistribution in rats of radiolabeled raloxifene. J Appl Radiat Isot 2010;68:33–6
- Murugesan S, Shetty SJ, Srivastava TS, et al. Preparation and biological evaluation of the new chlorine photosensitizer T3, 4BCPC for detection and treatment of tumors. J Photochem Photobiol B 2002;68:33–8
- Aprahamian M, Evrard S, Keller P, et al. Distribution of pheophorbide A in normal tissues and in an experimental pancreatic cancer in rats. Anticancer Drug Des 1993;8:101–14
- Josefsen LB, Boyle RW. Photodynamic therapy: novel third-generation photosensitizers. Metal Based Drugs 2008;1–24
- Goma I, Ali SE, El-Tayeb TA, Abdel-kader MH. Chlorophyll derivative mediated PDT versus methotrexate: an in vitro study using MCF-7 cells. Photodiagn Photodyn Therapy 2012;9:362–8